DE2516350A1 - Medicament applicator - for continuous intra-uterine injection at slow rate - Google Patents

Medicament applicator - for continuous intra-uterine injection at slow rate

Info

Publication number
DE2516350A1
DE2516350A1 DE19752516350 DE2516350A DE2516350A1 DE 2516350 A1 DE2516350 A1 DE 2516350A1 DE 19752516350 DE19752516350 DE 19752516350 DE 2516350 A DE2516350 A DE 2516350A DE 2516350 A1 DE2516350 A1 DE 2516350A1
Authority
DE
Germany
Prior art keywords
uterus
tube
anchor
application
uterine cavity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19752516350
Other languages
German (de)
Other versions
DE2516350B2 (en
DE2516350C3 (en
Inventor
Guenter Dr Med Franz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE19752516350 priority Critical patent/DE2516350C3/en
Publication of DE2516350A1 publication Critical patent/DE2516350A1/en
Publication of DE2516350B2 publication Critical patent/DE2516350B2/en
Application granted granted Critical
Publication of DE2516350C3 publication Critical patent/DE2516350C3/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Surgical Instruments (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Apparatus for continuous application of a liquid medicament in the uterine cavity, comprising a plastic anchor spirally adapted to the shape of the uterus having an application tube at its upper end perforated in the region of the uterus, in which the anchor with tube is applied through a tube in which it is introduced in stretched state, with a plunger via the neck channel of the uterus and can be easily removed again by means of a small cord, especially without undesirable side reactions. Makes possible the treatment with medicaments of the inner wall of the uterus e.g. for chronic inflammation diseases e.g. tuberculosis, pyometra, uterus mucus membrane cancer etc., particularly when continuous application over a period of e.g. up to 14 days is necessary.

Description

GERÄT FÜR DIE INTRAUTERINE DAUERAPPLIKATION FLÜSSIGER MEDIKAMENTE Die intrauterine Applikation von Medikamenten war bisher nicht möglich. Eingeführte Substanzen erbrachten nicht verantwortbare Nebenwirkungen, Flüssigkeiten ließen sich nicht wirkungsvoll applizieren, da es sich bei dem Cavum-uteri anatomisch nicht um einen Hohlraum handelt, sondern um einen kapillaren Spalt, der über den Halskanal der Gebärmutter direkt den Abfluß zurcheide hat. Das bedeutete, in den Hohlraum der Gebärmutter eingegebene flüssige Medikamente werden von der Gebärmutter so rasch wieder ausgeschieden, daß eine Einwirkung der Medikamente auf die Gebärmutterinnenwand nicht erfolgt.DEVICE FOR CONTINUOUS INTRAUTERINE APPLICATION OF LIQUID MEDICINES The intrauterine application of drugs has not been possible until now. Introduced Substances produced irresponsible side effects, liquids left cannot be applied effectively because the cavity uteri is not anatomically is a cavity, but a capillary gap that over the neck canal the uterus has the drainage directly through it. That meant in the cavity Liquid medication entered into the uterus is removed from the uterus so rapidly again excreted that an action of the drugs on the inner wall of the uterus not happened.

Der Erfindungsgegenstand ermöglicht die medikamentöse Behandlung der Gebärmutterinnenwand. Mit ihm kann man flüssige Medikamente an die Gebärmutterinnenwand in Form einer Dauerapplikation heranbringen und nachweislich Behandlungserfolge erzielen. Hierfür ist ein Applikationsschlauch erforderlich, der, möglichst feinperforiert, das durch ihn gegebene Medikament dauerhaft, feinberieselnd an die Gebärmutterinnenwand heranbringt. Ferner bedarf es einer Verankerung des Schlauches in der Gebärmutterhöhle. Der Anker muß leicht zu applizieren und auch leicht zu entfernen sein. Andererseits muß er sich in der Gebärmutterhöhle hinreichend fest verkanten, um nicht schon bei leichtem Zug wieder hinauszugleiten. Bei der Art der zu behandelnden Erkrankungen - chronisch entzündliche Prozesse wie Tuberkulose, Pyometra, Gebärmutterschleimhautkrebs - ist es erforderlich, die Dauerapplikation über Tage durchzuführen, z.B.The subject of the invention enables the drug treatment of the Inner wall of the uterus. With it you can apply liquid medication to the inner wall of the uterus in the form of a permanent application and demonstrable treatment success achieve. An application hose is required for this, which is as finely perforated as possible, the medication given by him permanently, finely sprinkling on the inner wall of the uterus brings up. The tube must also be anchored in the uterine cavity. The anchor must be easy to apply and also easy to remove. on the other hand it has to be canted firmly enough in the uterine cavity in order not to start with slide out again with a gentle pull. In the nature of the diseases to be treated - chronic inflammatory processes such as tuberculosis, pyometra, endometrial cancer - it is necessary to carry out the continuous application over days, e.g.

über Zeiträume von 14 Tagen. Die Verankerung muß also auch so beschaffen sein, daß sie den Applikationsschlauch über Wochen korrekt situiert im Gebärmuttercavum festhält und die Gebärmutterwand nicht zusätzlich schädigt.over periods of 14 days. So the anchoring must also be that way be, that the application tube is positioned correctly in the uterine cavity for weeks and does not damage the uterine wall additionally.

Erfindungsgemäß wurde das wie folgt erreicht: Eine Kunststoffspirale, wie sie z.B. zur Schwangerschaftsverhütung bekannt ist, die also über längere Zeit in der Gebärmutterhöhle verbleiben kann, ohne Schäden anzurichten, wurde mit einem Applikationsschlauch versehen. Dieser Applikationsschlauch wurde am obersten Pol der Kunststoff spirale befestigt. Er wurde also im Bereich des Uterusdaches fixiert und zum Halskanal der Gebärmutter hinausgeleitet. Perforiert ist der Schlauch nur in dem Abschnitt, der mit Sicherheit im Bereich der Gebärmutterhöhle zu liegen kommt. Der spiralenförmige Anker, der den Applikationsschlauch in richtiger Lage fixiert, ist leicht in die Gebärmutterhöhle einzubringen, weil er gestreckt werden kann und dann durch ein Rohr, in welchem er gestreckt eingebracht wird, mit einem Stempel durch den Halskanal in die Gebärmutterhöhle geschoben wird, in welcher er sofort die Spiralform annimmt (Zeichnung}.According to the invention this was achieved as follows: A plastic spiral, as it is known e.g. for contraception, i.e. over a longer period of time can remain in the uterine cavity without causing damage, was with a Provide application hose. This application tube was at the top pole attached to the plastic spiral. It was therefore fixed in the area of the roof of the uterus and led out to the cervical canal of the uterus. The hose is only perforated in the section that will definitely come to lie in the area of the uterine cavity. The spiral-shaped anchor that fixes the application hose in the correct position, is easy to insert into the uterine cavity because it can be stretched and then through a tube, in which it is inserted stretched, with a punch is pushed through the cervical canal into the uterine cavity, in which it is immediately takes on the spiral shape (drawing).

So in richtige Position gebracht, kann über Stunden bis Wochen das gewünschte Medikament so langsam in die Gebärmutterhöhle gegeben werden, daß eine Beeinflussung der Gebärmutterwand erfolgt.Put in the right position in this way can take hours or weeks The desired drug can be introduced into the uterine cavity so slowly that one Affecting the uterine wall takes place.

Bei Beendigung der Behandlung wird der liegende Anker mit einem Fädchen, das aus dem Muttermundsbereich heraushängt, mit leichtem Zug entfernt.At the end of the treatment, the lying anchor is fastened with a thread, that hangs out of the cervical area, removed with a slight pull.

Mit dem Erfindungsgegenstand wurden bisher 76 Fälle von Genitaltuberkulose behandelt. Es wurde damit eine eindeutige Verbesserung der Tuberkulosebehandlungsmethode erreicht. Dies war bakteriologisch , histologisch und palpatorisch zu beweisen. Bei Vereiterungen der Gebärmutterhöhle (Pyometra) ist die Behandlung mit dem Erfindungsgegenstand von größtem Wert. Es bahnen sich günstige Beeinflussungen von Gebärmutterschleimhautkrebsen an.With the subject invention so far 76 cases of genital tuberculosis have been identified treated. It was a definite improvement in the tuberculosis treatment method achieved. This could be proven bacteriologically, histologically and palpatorily. In the case of suppuration of the uterine cavity (pyometra), treatment is with the subject of the invention of great value. Favorable influences from endometrial cancer are developing at.

Darüber hinaus ist eine Röntgendarstellung der Gebärmutterhöhle mit diesem Gerät von großtem Wert <Perfusionshysterogram nach Franz) PatentansprücheIn addition, an x-ray image of the uterine cavity is included this device of great value <perfusion hysterogram according to Franz) claims

Claims (1)

Patentansprüche : Gerät zur Dauerapplikation flüssiger Medikamente in die Gebärmutterhöhle dadurch gekennzeichnet, daß ein spiralförmiger der Form der Gebärmutter angepaßter Anker aus Kunststoff an seinem oberen Ende mit einem am Bereich der Gebärmutter perforierten Applikationsschlauch versehen wird, wobei der Anker mit Schlauch durch ein Rohr, in welches er gestreckt eingebracht wird, mit einem Stempel durch den Halskanal der Gebärmutter appliziert und mittels eines Fädchens leicht wieder entfernt werden kann, und zwar ohne unerwünschte Nebenwirkungen.Claims: Device for the continuous application of liquid medication in the uterine cavity characterized in that a spiral of the shape the uterus adapted anchor made of plastic at its upper end with a at the area of the uterus perforated application tube is provided, wherein the anchor with hose through a pipe into which it is inserted stretched, applied with a stamp through the cervical canal of the uterus and by means of a The thread can easily be removed again without any undesirable side effects. Zeichnung Leerseitedrawing Blank page
DE19752516350 1975-04-15 1975-04-15 Device for the application of liquid medication into the uterine cavity Expired DE2516350C3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19752516350 DE2516350C3 (en) 1975-04-15 1975-04-15 Device for the application of liquid medication into the uterine cavity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752516350 DE2516350C3 (en) 1975-04-15 1975-04-15 Device for the application of liquid medication into the uterine cavity

Publications (3)

Publication Number Publication Date
DE2516350A1 true DE2516350A1 (en) 1976-10-21
DE2516350B2 DE2516350B2 (en) 1977-11-03
DE2516350C3 DE2516350C3 (en) 1978-06-22

Family

ID=5943893

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752516350 Expired DE2516350C3 (en) 1975-04-15 1975-04-15 Device for the application of liquid medication into the uterine cavity

Country Status (1)

Country Link
DE (1) DE2516350C3 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996031250A1 (en) * 1995-04-06 1996-10-10 Richwood Pharmaceuticals Company, Inc. Infusor system for delivery of medication to a body cavity
US7431717B2 (en) 2003-09-30 2008-10-07 Serene Medical, Inc. Central nervous system administration of medications by means of pelvic venous catheterization and reversal of Batson's Plexus

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996031250A1 (en) * 1995-04-06 1996-10-10 Richwood Pharmaceuticals Company, Inc. Infusor system for delivery of medication to a body cavity
GB2314777A (en) * 1995-04-06 1998-01-14 Richwood Pharmaceuticals Compa Infusor system for delivery of medication to a body cavity
US5830186A (en) * 1995-04-06 1998-11-03 G. & P. Technologies, Inc. Method of dispensing medications by use of mucous membrane infusor
US5846216A (en) * 1995-04-06 1998-12-08 G & P Technologies, Inc. Mucous membrane infusor and method of use for dispensing medications
GB2314777B (en) * 1995-04-06 1999-04-28 Richwood Pharmaceuticals Compa Mucous membrane infusor
US7431717B2 (en) 2003-09-30 2008-10-07 Serene Medical, Inc. Central nervous system administration of medications by means of pelvic venous catheterization and reversal of Batson's Plexus

Also Published As

Publication number Publication date
DE2516350B2 (en) 1977-11-03
DE2516350C3 (en) 1978-06-22

Similar Documents

Publication Publication Date Title
DE2101533A1 (en) Device for the dosed delivery of medication
Csapo The prospects of PGs in postconceptional therapy
DE2320250A1 (en) ABORTUS FACILITATING DEVICE
DE202013001998U1 (en) Catheter, in particular for the treatment of prostate and / or bladder, and kit containing this catheter
DE3105956A1 (en) &#34;DEVICE FOR ADMINISTRATING MEDICAL EYE MATERIALS&#34;
DE2516350A1 (en) Medicament applicator - for continuous intra-uterine injection at slow rate
DE2537620A1 (en) Balloon pessary for blocking fallopian tubes - is inflatable double balloon containing X:ray opaque thread in wall
DE69305194T2 (en) Intrauterine and / or intravaginal device
DE1250058B (en) Indwelling probe for emptying the male urinary bladder
Hegglin et al. Maligne Tumoren bei Dermatomyositis
DE645765C (en) Irrigator for vaginal douching
CN204684429U (en) A kind of medicine controlled releasing apparatus
DE1295132B (en) Support sleeve
EP0797429B1 (en) Osmotic device for the continuous release of active substances into the fluids of the gastro-intestinal tract
DE923988C (en) Intestinal and vaginal tampon for animals
DE1931408A1 (en) Uterus treatment apparatus
AT233164B (en) Contraceptive device and device for its introduction
Balin et al. Low dosage megestrol acetate application as contraceptive
DE6935815U (en) DEVICE FOR THE TREATMENT OF FEMALE GENITAL ORGANS TO REMOVE VAGINAL DRYNESS AND POTENTIAL DISORDERS
DE10243917A1 (en) Device for subcutaneous delivery of a pharmaceutical product is introducible through the skin so that its subcutaneous part contains a system for controlled release of the product
DE202021105274U1 (en) Device for providing drug solutions for the intravesical treatment of infections of the urinary bladder
Bánk Hochdruck-Hydrotubation mit Hyaluronidase zur Eröffnung okkludierter Tuben
AT208504B (en) Device for irrigation and therapeutic treatment of the human vagina and vulva
DE2057734A1 (en) Device for increasing the performance in case of impotence and weakness
DE1864816U (en) DEVICE FOR ADMINISTRATION OF DRUGS OR. DGL. INTO THE WOMEN OF BIG ANIMALS.

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee